BackFrazier Lifesciences Acquisition - Warrants (09/12/2025) Overview

Frazier Lifesciences Acquisition - Warrants (09/12/2025) Other Current Assets

Latest other current assets for FLACW: $69K.

Get informed when a big investor buys or sells

+ Follow
Other Current Assets
$69216.00
79.08% YoYΔ $-261617.00 vs prior year quarter

Peer average / median

Loading

Frazier Lifesciences Acquisition - Warrants (09/12/2025) Other Current Assets History

Loading

Frazier Lifesciences Acquisition - Warrants (09/12/2025) vs. peers: Other Current Assets Comparison

Loading

Frazier Lifesciences Acquisition - Warrants (09/12/2025) Other Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Frazier Lifesciences Acquisition - Warrants (09/12/2025) (FLACW) FAQ

The latest other current assets for FLACW is $69K as of September 2022. That compares with $330K in the prior-year period — down 79.1% year over year. Investors often review this figure alongside Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s historical trend and sector peers before judging valuation or financial health.

Over the past year, FLACW's other current assets moved from $330K to $69K — a 79.1% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Frazier Lifesciences Acquisition - Warrants (09/12/2025)'s operating scale or balance-sheet position.

A other current assets figure of $69K for FLACW is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. Explore the charts below for those layers of context.

After noting FLACW's other current assets ($69K), review year-over-year change from $330K, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.